We are live on ! Find out more

2,996 hedge funds and large institutions have $100B invested in Pfizer in 2024 Q4 according to their latest regulatory filings, with 381 funds opening new positions, 934 increasing their positions, 1,466 reducing their positions, and 246 closing their positions.

New
Increased
Maintained
Reduced
Closed

55% more first-time investments, than exits

New positions opened: 381 | Existing positions closed: 246

3% more funds holding

Funds holding: 2,9102,996 (+86)

0% more funds holding in top 10

Funds holding in top 10: 4242 (0)

0.21% less ownership

Funds ownership: 66.47%66.25% (-0.21%)

8% less capital invested

Capital invested by funds: $109B → $100B (-$8.72B)

15% less call options, than puts

Call options by funds: $3.28B | Put options by funds: $3.87B

36% less repeat investments, than reductions

Existing positions increased: 934 | Existing positions reduced: 1,466

Holders
2,996
Holders Change
+86
Holders Change %
+2.96%
% of All Funds
39.46%
Holding in Top 10
42
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.55%
New
381
Increased
934
Reduced
1,466
Closed
246
Calls
$3.28B
Puts
$3.87B
Net Calls
-$595M
Net Calls Change
+$945M
Name Holding Trade Value Shares
Change
Change in
Stake
Koshinski Asset Management
26
Koshinski Asset Management
Illinois
$563M -$75.7K -2,789 -12%
BNP Paribas Financial Markets
27
BNP Paribas Financial Markets
France
$502M -$196M -7,221,865 -28%
T. Rowe Price Associates
28
T. Rowe Price Associates
Maryland
$501M -$56.5M -2,084,603 -10%
Diamond Hill Capital Management
29
Diamond Hill Capital Management
Ohio
$494M +$56.1M +2,069,359 +13%
Goldman Sachs
30
Goldman Sachs
New York
$459M -$231M -8,507,851 -33%
Barclays
31
Barclays
United Kingdom
$448M -$277M -10,203,305 -38%
HSBC Holdings
32
HSBC Holdings
United Kingdom
$441M -$36.6M -1,347,656 -7%
Franklin Resources
33
Franklin Resources
California
$435M -$687K -25,315 -0.2%
California Public Employees Retirement System
34
California Public Employees Retirement System
California
$426M -$798K -29,435 -0.2%
Swiss National Bank
35
Swiss National Bank
Switzerland
$425M -$22M -811,400 -5%
SV
36
Starboard Value
New York
$408M +$417M +15,368,658 New
N
37
Nuveen
North Carolina
$402M -$16.9M -621,603 -4%
Citadel Advisors
38
Citadel Advisors
Florida
$395M +$185M +6,811,116 +84%
Ameriprise
39
Ameriprise
Minnesota
$394M -$144M -5,299,962 -26%
Federated Hermes
40
Federated Hermes
Pennsylvania
$382M -$16.3M -601,995 -4%
First Trust Advisors
41
First Trust Advisors
Illinois
$381M +$65.8M +2,426,546 +20%
Sumitomo Mitsui Trust Group
42
Sumitomo Mitsui Trust Group
Japan
$373M +$26M +956,873 +7%
LSV Asset Management
43
LSV Asset Management
Illinois
$365M +$21.9M +807,215 +6%
UE
44
Unisphere Establishment
Liechtenstein
$336M
National Pension Service
45
National Pension Service
South Korea
$315M +$9.2M +339,178 +3%
National Bank of Canada
46
National Bank of Canada
Quebec, Canada
$307M +$79.3M +2,925,269 +34%
Fisher Asset Management
47
Fisher Asset Management
Washington
$296M +$134M +4,938,209 +80%
1832 Asset Management
48
1832 Asset Management
Ontario, Canada
$286M +$147M +5,410,759 +101%
Bank of Montreal
49
Bank of Montreal
Ontario, Canada
$286M -$125M -4,605,455 -30%
Fidelity Investments
50
Fidelity Investments
Massachusetts
$285M -$101M -3,722,469 -26%

PFE Hedge Fund Activity: Q4 2024 in Review

2,996 of the 7,593 institutional investors tracked by Wall St. Rank reported a position in Pfizer (PFE) for Q4 2024, worth a combined $100B — down 8% from $109B a quarter earlier.

Buyers outnumbered sellers: 381 funds opened new PFE positions and 246 closed out — a net gain of 135 holders — while 934 added to existing stakes and 1,466 trimmed.

The largest buyer was Charles Schwab, adding an estimated $687M. The largest seller was Wellington Management Group, cutting an estimated $644M.

  • 2,996 institutional investors held Pfizer (PFE) as of Q4 2024, up from 2,910 in Q3 2024.
  • Funds reported $100B of Pfizer stock for Q4 2024, down 8% quarter-over-quarter.
  • 381 funds opened new Pfizer positions in Q4 2024 and 246 closed out, a net change of +135 holders.
  • The largest Pfizer buyer in Q4 2024 was Charles Schwab, an estimated $687M added.
  • The largest Pfizer seller in Q4 2024 was Wellington Management Group, an estimated $644M sold.

Based on aggregated 13F filings for Q4 2024.